Medtronic earns FDA approval for insertable cardiac monitor

Medtronic received market clearance from the Food and Drug Administration for its insertable cardiac monitor.

Advertisement

Clinicians insert the Reveal LINQ Insertable Cardiac Monitor in the upper left side of a patient’s chest during a minimally invasive procedure. The implanted device allows clinicians to continuously monitor a patient’s heartbeat for up to three years, according to a company news release.

The device uses wireless communication to upload device data, and patients can undergo MRIs while using the implanted device.

More articles on supply chain:

Patients often skip, delay or ration cancer treatments due to high drug costs: 5 takeaways
7 things to know about Dr. Scott Gottlieb’s relationship with the drug industry
Mylan settles biosimilar patent dispute with Roche: 4 things to know

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.